|
|
pfizer, придобиване, cellectis, противоракови терапии, novartis, kite pharma, juno therapeutics, т-клетъчни химерични антигенни рецептори, car-t, злокачествени заболявания, солидни тумори, онкологичния пазар, партнират, merck kgaa, anti-pd-l1, programmed death-ligand 1, антитяло, msb0010718c,teva, дял, mylan,endo, закупуване, par pharmaceutical, сделка, генеричен бизнес, salix pharmaceuticals, valeant pharmaceuticals,alexion pharmaceuticals, споразумение за придобиване, synageva biopharma, kanuma, sebelipase alfa, lal, lysosomal acid lipase, недостатъчност, soliris, eculizumab, атипичен хемолитичен уремичен синдром.,perrigo, предложение за закупуване
pfizerq m,rof/rldkeq cellectisq m,fjrlf,duflr je,dmrrq novartisq kite pharmaq juno therapeuticsq j-u.ejc'kr nr;e,r'kr dkjrhekkr ,e[emjf,rq car-tq p.fud'eijlekr pd/f.sldkrsq if.rokr jw;f,rq fkuf.fhr'krs mdpd,q md,jkr,djq merck kgaaq anti-pd-l1q programmed death-ligand 1q dkjrjs.fq msb0010718cqtevaq os.q mylanqendoq pduwmwldkeq par pharmaceuticalq ioe.udq heke,r'ek /rpkeiq salix pharmaceuticalsq valeant pharmaceuticalsqalexion pharmaceuticalsq imf,dpw;ekre pd m,rof/rldkeq synageva biopharmaq kanumaq sebelipase alfaq lalq lysosomal acid lipaseq keofijdjc'kfijq solirisq eculizumabq djrmr'ek ne;f.rjr'ek w,e;r'ek irko,f;.qperrigoq m,eo.fgekre pd pduwmwldke
pfizer, pridobiwane, cellectis, protiworakowi terapii, novartis, kite pharma, juno therapeutics, t-klety`ni himeri`ni antigenni receptori, car-t, zloka`estweni zabolqwaniq, solidni tumori, onkologi`niq pazar, partnirat, merck kgaa, anti-pd-l1, programmed death-ligand 1, antitqlo, msb0010718c,teva, dql, mylan,endo, zakupuwane, par pharmaceutical, sdelka, generi`en biznes, salix pharmaceuticals, valeant pharmaceuticals,alexion pharmaceuticals, sporazumenie za pridobiwane, synageva biopharma, kanuma, sebelipase alfa, lal, lysosomal acid lipase, nedostaty`nost, soliris, eculizumab, atipi`en hemoliti`en uremi`en sindrom.,perrigo, predlovenie za zakupuwane
pfizer, pridobivane, cellectis, protivorakovi terapii, novartis, kite pharma, juno therapeutics, t-kletyqni himeriqni antigenni receptori, car-t, zlokaqestveni zabol[vani[, solidni tumori, onkologiqni[ pazar, partnirat, merck kgaa, anti-pd-l1, programmed death-ligand 1, antit[lo, msb0010718c,teva, d[l, mylan,endo, zakupuvane, par pharmaceutical, sdelka, generiqen biznes, salix pharmaceuticals, valeant pharmaceuticals,alexion pharmaceuticals, sporazumenie za pridobivane, synageva biopharma, kanuma, sebelipase alfa, lal, lysosomal acid lipase, nedostatyqnost, soliris, eculizumab, atipiqen hemolitiqen uremiqen sindrom.,perrigo, predloxenie za zakupuvane
|
|
|
